Agomelatine structure
|
Common Name | Agomelatine | ||
---|---|---|---|---|
CAS Number | 138112-76-2 | Molecular Weight | 243.301 | |
Density | 1.1±0.1 g/cm3 | Boiling Point | 478.8±28.0 °C at 760 mmHg | |
Molecular Formula | C15H17NO2 | Melting Point | 107-109ºC | |
MSDS | Chinese USA | Flash Point | 243.4±24.0 °C | |
Symbol |
GHS09 |
Signal Word | Warning |
Use of AgomelatineAgomelatine is a competitive antagonist of human and porcine serotonin (5-HT2C) receptors (pKi = 6.2 and 6.4, respectively) as well as human 5-HT2B receptors (pKi = 6.6). IC50 value: 6.2 (pKi, 5-HT2c); 6.6 (pKi, 5-HT2b)Target: 5-HT2C Receptor; 5-HT2B receptorIt is classified as a norepinephrine-dopamine disinhibitor (NDDI) due to its antagonism of the 5-HT2C receptor. Activation of 5-HT2C receptors by serotonin inhibits dopamine and norepinephrine release. Antagonism of 5-HT2C results in an enhancement of DA and NE release and activity of frontocortical dopaminergic and adrenergic pathways. Agomelatine is also a potent agonist at melatonin receptors which makes it the first melatonergic antidepressant. Agomelatine is an antidepressant drug. |
Name | Agomelatine |
---|---|
Synonym | More Synonyms |
Description | Agomelatine is a competitive antagonist of human and porcine serotonin (5-HT2C) receptors (pKi = 6.2 and 6.4, respectively) as well as human 5-HT2B receptors (pKi = 6.6). IC50 value: 6.2 (pKi, 5-HT2c); 6.6 (pKi, 5-HT2b)Target: 5-HT2C Receptor; 5-HT2B receptorIt is classified as a norepinephrine-dopamine disinhibitor (NDDI) due to its antagonism of the 5-HT2C receptor. Activation of 5-HT2C receptors by serotonin inhibits dopamine and norepinephrine release. Antagonism of 5-HT2C results in an enhancement of DA and NE release and activity of frontocortical dopaminergic and adrenergic pathways. Agomelatine is also a potent agonist at melatonin receptors which makes it the first melatonergic antidepressant. Agomelatine is an antidepressant drug. |
---|---|
Related Catalog | |
References |
[5]. Agomelatine |
Density | 1.1±0.1 g/cm3 |
---|---|
Boiling Point | 478.8±28.0 °C at 760 mmHg |
Melting Point | 107-109ºC |
Molecular Formula | C15H17NO2 |
Molecular Weight | 243.301 |
Flash Point | 243.4±24.0 °C |
Exact Mass | 243.125931 |
PSA | 38.33000 |
LogP | 2.27 |
Vapour Pressure | 0.0±1.2 mmHg at 25°C |
Index of Refraction | 1.582 |
Storage condition | -20°C Freezer |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Precursor 8 | |
---|---|
DownStream 2 | |
HS Code | 2924299090 |
---|---|
Summary | 2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
[The activity of glutathione antioxidant system at melaksen and valdoxan action under experimental hyperthyroidism in rats].
Biomed. Khim. 59(5) , 541-9, (2013) Investigation of glutathione antioxidant system activity and diene conjugates content in rats liver and blood serum at the influence of melaksen and valdoxan under experimental hyperthyroidism (EG) ha... |
|
[Tachycardia and precordial pain with agomelatine: a case report].
Therapie. 68(5) , 324-5, (2013)
|
|
Agomelatine, melatonin and depressive disorder.
Expert Opin. Investig. Drugs 22(4) , 407-10, (2013) Alteration of nocturnal melatonin production, along with circadian rhythm disturbance, has been demonstrated in several psychiatric disorders. It has been postulated that such disturbances might be ca... |
Unii-137R1N49ad |
N-[2-(7-Methoxy-1-naphthyl)ethyl]acetamide |
Acetamide, N-[2-(7-methoxy-1-naphthalenyl)ethyl]- |
Aglomelatine |
Agomelatine |
N-[2-(7-Methoxy-1-naphthalenyl)ethyl]-acetamide S-20098 |
AGOMELATIN |
Valdoxan |
N-(2-(7-Methoxynaphthalen-1-yl)ethyl)acetamide |
N-[2-(7-Methoxy-1-naphthalenyl)ethyl]acetamide |
Melitor |
Thymanax |